The study of the impact of changes in surface antigens on eosinophils after treatment in patients with asthma
Not Applicable
- Conditions
- Patients with asthma and asthma suspicion
- Registration Number
- JPRN-UMIN000052207
- Lead Sponsor
- Kurume University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Not provided
Exclusion Criteria
1) current and ex-heavy smokers (>10pack-year) 2) Immunosuppressive patients with active cancer and HIV infections 3) History of patients with lung resections 4) During severe or fatal asthma exacerbations 5) Other chronic respiratory diseases
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The low CD62- and CD34-positive eosinophils at pre-treatment and early improvement of CD62- and CD34-positive eosinophils after treatment are estimable biomarkers of clinical remission of asthma.
- Secondary Outcome Measures
Name Time Method